With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers. The pharmaceuticals sector is pivotal in the development, manufacturing, and distribution of drugs and ...

While JAZZ Pharmaceuticals JAZZ may not be a typical cannabis stock, it is the only company to market an FDA-approved drug that contains a purified drug substance derived from marijuana.

Jazz Pharmaceuticals Stock Performance Shares of NASDAQ:JAZZ opened at $102.91 on Wednesday. The business has a 50-day moving average of $128.93 and a two-hundred day moving average of $122.56 ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers. The pharmaceuticals ...

Dublin, Ireland-based Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus on neuroscience and oncology. JAZZ is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...